In-Depth Examination Of 18 Analyst Recommendations For Boston Scientific
Portfolio Pulse from Benzinga Insights
In the past three months, 18 analysts have shared their insights on Boston Scientific (NYSE:BSX), with most ratings being bullish. The average 12-month price target has increased by 6.27% to $87.33. Analysts have raised their ratings and price targets, reflecting positive sentiment towards the company. Boston Scientific has shown revenue growth and strong net margins, but faces challenges with ROE and ROA.
August 22, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific has received predominantly bullish analyst ratings, with an increase in the average 12-month price target to $87.33. Analysts have raised their ratings and price targets, indicating positive sentiment. The company shows strong revenue growth and net margins, but faces challenges with ROE and ROA.
The majority of analysts have given bullish ratings, and the average price target has increased, indicating positive sentiment. The company's strong revenue growth and net margins support this outlook, although challenges with ROE and ROA are noted.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100